Biologics Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Trends Analysis Report By Type (Mammalian, Non-mammalian (Microbial)), By Product Type (Biologics, Biosimilars) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031
The global healthcare contract development and manufacturing organization market size was valued at USD 221.97 billion in 2021. It is projected to reach USD 476.55 billion by 2030, growing at a CAGR of 8.86% during the forecast period (2022–203
The global pharmaceutical contract development and manufacturing organization (CDMO) market size was valued at USD 196.54 billion in 2023. It is expected to reach USD 309.44 billion by 2032, growing at a CAGR of 6.6% during the forecast period (2024&
You will receive a link to download the sample pages on your email immediately after filling out a form
A sample report will help you understand the structure of our full report
The sample shared will be for our off-the-shelf market report
The off-the-shelf report is curated considering a broader audience for this market, we have insights extending well beyond the scope of this report. Please reach out to discuss
Should the sample pages not contain the specific information you seek, we extend the option to request additional details, which our dedicated team will incorporate.
The sample is free of cost, while the full report is available for a fee.